MARKET

INM

INM

Inmed Pharmaceuticals Inc
NASDAQ
1.570
-0.110
-6.55%
After Hours: 1.520 -0.05 -3.18% 19:42 05/29 EDT
OPEN
1.650
PREV CLOSE
1.680
HIGH
1.650
LOW
1.550
VOLUME
200.49K
TURNOVER
--
52 WEEK HIGH
7.98
52 WEEK LOW
0.5750
MARKET CAP
5.20M
P/E (TTM)
-0.5450
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at INM last week (0518-0522)?
Weekly Report · 6d ago
Weekly Buzz: GH Wins FDA Nod; NMPA Green Lights HCM; MDT To Acquire SPR ; BIIB HALTS BIIB112
NASDAQ · 05/22 14:47
ADAR1 Capital Management acquires 468,551 InMed common shares worth $742,290
PUBT · 05/21 21:08
InMed Pharmaceuticals files Form 3 showing ADAR1 Capital Management stake of 331,449 shares
PUBT · 05/21 20:51
INM Stock Alert: What to Know as InMed, Mentari Announce Merger
Barchart · 05/20 12:01
BUZZ-U.S. STOCKS ON THE MOVE- Hims & Hers Health, Driven Brands, Onto Innovation
Reuters · 05/19 17:42
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 05/19 17:06
Gold Falls 1%; Amer Sports Earnings Top Views
Benzinga · 05/19 16:29
More
About INM
InMed Pharmaceuticals Inc. is a pharmaceutical company. The Company develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharma segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is a small molecule drug candidate being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.

Webull offers InMed Pharmaceuticals Inc stock information, including NASDAQ: INM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INM stock methods without spending real money on the virtual paper trading platform.